Alzheimer's Approval, COVID-19 Vaccines Put Spotlight On Biotech Sector, But What's Next?
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
For most of the past year, just a handful of companies carried the biotech sector, thanks to their quick responses to the COVID-19 pandemic.